Osimertinib, also known as Tagrisso and made by AstraZeneca, can help stop cancer from returning after surgery ...
According to Nice, osimertinib can help stop cancer from returning after surgery by targeting cells that have specific ...
A DAILY pill that doubles survival time for lung cancer patients will be made routinely available on the NHS. Osimertinib, also known as Tagrisso and made by AstraZeneca, helps prevent cancer from ...
During a Community Case Forum event in partnership with the Medical Oncology Association of Southern California, Edward S.
During a Case-Based Roundtable® event, Joshua K. Sabari, MD, continued discussion of key outcomes from the MARIPOSA trial and ...
UK pharma major AstraZeneca today revealed that, this week, it has received two positive recommendations from the National ...
GlobalData on MSN2d
AstraZeneca gains NICE nod for lung cancer drugs Tagrisso and ImfinziTagrisso and Imfinzi are projected to generate global sales of $8bn and $7bn, respectively, by 2030, according to GlobalData.
AstraZeneca announced that this week it has received two positive recommendations from the National Institute for Health and Care Excellence (NICE) for the treatment of lung cancer patients across ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback